• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD MEDICAL - DIABETES CARE BD MICRO-FINE¿ INSULIN SYRINGE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD MEDICAL - DIABETES CARE BD MICRO-FINE¿ INSULIN SYRINGE Back to Search Results
Catalog Number 324826
Device Problems Out-Of-Box Failure (2311); Material Deformation (2976)
Patient Problem No Patient Involvement (2645)
Event Date 12/05/2017
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that discolorations were found inside bd micro-fine¿ insulin syringe needles prior to use.There was no report of injury or medical intervention.
 
Manufacturer Narrative
Investigation summary: nine (9) 3/10cc, 8mm, 30g syringes were returned in open poly bags from lot # 7044865.Customer states that there is discoloration inside the syringes.All returned syringes were examined under the microscope and all exhibited smeared ink on the surface of the barrel.No discoloration was observed inside the barrel.Capa (b)(4) was initiated to address such issues at this time.As per manufacturing, a review of the device history record was completed for batch # 7044865 all inspections were performed per the applicable operations qc specifications.Based on the samples / photo(s) received the investigation concluded: confirmed: bd was able to duplicate or confirm the customer¿s indicated failure.Investigation conclusion: possible root cause is attributed to pad swelling on the mandrill during the printing process.As the pads are used, they gradually swell and can cause this type of "smear" or "smudge affect.A problem solving team has been tasked with improving print quality on all production lines within the plant.The team is systematically assessing and addressing each printer individually for improvements.Capa (b)(4) was initiated to address such issues at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD MICRO-FINE¿ INSULIN SYRINGE
Type of Device
INSULIN SYRINGE
Manufacturer (Section D)
BD MEDICAL - DIABETES CARE
1329 west highway 6
holdrege NE 68949
MDR Report Key7154804
MDR Text Key96124913
Report Number1920898-2017-00403
Device Sequence Number1
Product Code FMF
Combination Product (y/n)N
PMA/PMN Number
K955235
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 02/26/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/29/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date02/28/2022
Device Catalogue Number324826
Device Lot Number7044865
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/15/2017
Date Manufacturer Received12/06/2017
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-